ATSA Injection Substitute
by BD
by Others
by Others
by AYUR
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
Composition:
AZACITIDINE-100MG
Uses:
ATSA Injection is used in the treatment of Myelodysplastic syndrome, chronic myelomonocytic leukaemia, and acute myeloid leukaemia. The detailed uses of ATSA Injection are as follows:<br/>• Myelodysplastic Syndromes (MDS): ATSA Injection helps improve blood counts and reduce the need for transfusions.<br/>• Acute Myeloid Leukemia (AML): ATSA Injection is used especially in patients who are in remission but cannot undergo intensive chemotherapy.<br/>• Chronic Myelomonocytic Leukemia (CMML): ATSA Injection is used to treat MDS and myeloproliferative disorders.<br/>
Medicinal Benefits:
ATSA Injection belongs to the group of medicines called anti-metabolites used to treat myelodysplastic syndromes, chronic myelomonocytic leukaemia, and acute myeloid leukaemia. ATSA Injection contains Azacitidine, a nucleoside metabolic inhibitor which works by preventing cancer cells from growing. It incorporates into the genetic material of the cells and interferes with the production of new DNA and RNA. This helps correct problems with the maturation and growth of young blood cells in the bone marrow, which causes myelodysplastic disorders.
ATSA Injection is used to treat Myelodysplastic syndrome, chronic myelomonocytic leukaemia, and acute myeloid leukaemia.
ATSA Injection works by preventing cancer cells from growing. Thereby, it helps treat cancer.
Men should avoid fathering a child whilst on treatment with ATSA Injection. Consult the doctor if you wish to conserve your sperm before starting the treatment. Use effective contraception during the treatment with ATSA Injection and for three months after stopping the treatment.
ATSA Injection may cause a serious immune reaction known as differentiation syndrome. Consult the doctor immediately if you experience fever, rash, difficulty breathing, cough, decreased urine, rapid weight gain, low blood pressure, or swelling of the legs or arms.
No, ATSA Injection is not a vesicant. It is a cytotoxic chemotherapy drug used to treat certain types of blood cancer, such as myelodysplastic syndrome (MDS). It is not known to cause severe tissue damage if it leaks from the injection site.
No, ATSA Injection does not cause hair loss.
Yes, ATSA Injection is a type of chemotherapy. It is used to treat certain types of blood cancers, such as myelodysplastic syndrome (MDS) and some forms of leukaemia.
Yes, ATSA Injection is a cytotoxic drug. It works by interfering with the growth of cancer cells, which helps to slow down or stop their multiplication.
The common side effects of ATSA Injection are nausea, vomiting, diarrhoea, constipation, weakness, headache, and injection site reactions. If any of these side effects persist or worsen, please consult your doctor.